{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:23:27Z","timestamp":1785767007577,"version":"3.56.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003008","name":"Ministry of Higher Education, Egypt","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003008","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ejps.2019.03.016","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T20:18:58Z","timestamp":1553199538000},"page":"115-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"special_numbering":"C","title":["Exploiting gelatin nanocarriers in the pulmonary delivery of methotrexate for lung cancer therapy"],"prefix":"10.1016","volume":"133","author":[{"given":"Hend","family":"Abdelrady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania M.","family":"Hathout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihab","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2382-6668","authenticated-orcid":false,"given":"Imran","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahed D.","family":"Mortada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2019.03.016_bb0005","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ijbiomac.2013.11.041","article-title":"Towards better modeling of chitosan nanoparticles production: screening different factors and comparing two experimental designs","volume":"64","author":"Abdel-Hafez","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejps.2019.03.016_bb0010","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.colsurfb.2016.05.066","article-title":"Silencing of the metastasis-linked gene, AEG-1, using siRNA-loaded cholamine surface-modified gelatin nanoparticles in the breast carcinoma cell line MCF-7","volume":"145","author":"Abozeid","year":"2016","journal-title":"Colloids Surf. B. Biointerfaces."},{"key":"10.1016\/j.ejps.2019.03.016_bb0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/02652048.2013.834991","article-title":"Characterisation, cytotoxicity and apoptosis studies of methotrexate-loaded PLGA and PLGA-PEG nanoparticles","volume":"31","author":"Afshari","year":"2014","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejps.2019.03.016_bb0020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jphotobiol.2015.09.006","article-title":"Synthesis, characterization and in vitro evaluation of methotrexate conjugated fluorescent carbon nanoparticles as drug delivery system for human lung cancer targeting","volume":"153","author":"Ajmal","year":"2015","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.ejps.2019.03.016_bb0025","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1002\/jps.24681","article-title":"Pulmonary delivery of proteins using nanocomposite microcarriers","volume":"104","author":"Alfagih","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.03.016_bb0030","first-page":"128","article-title":"Recent advances using supercritical fluid techniques for pulmonary administration of macromolecules via dry powder formulations","volume":"1","author":"Al-fagih","year":"2011","journal-title":"Drug Del. Lett."},{"key":"10.1016\/j.ejps.2019.03.016_bb0035","first-page":"124","article-title":"Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells","volume":"9","author":"Azarmi","year":"2006","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.03.016_bb0040","first-page":"733","article-title":"Formulation and evaluation of gelatin nanoparticles for pulmonary drug delivery","volume":"3","author":"Bharti","year":"2014","journal-title":"World J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.03.016_bb0045","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0168-3659(00)00362-X","article-title":"Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance","volume":"70","author":"Bosquillon","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2019.03.016_bb0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/adfm.200390029","article-title":"Chemical and structural investigations of biomimetically grown fluorapatite\u2013gelatin composite aggregates","volume":"13","author":"Busch","year":"2003","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ejps.2019.03.016_bb0055","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/026520400288427","article-title":"Gelatin nanoparticles by two step desolvation\u2014a new preparation method, surface modifications and cell uptake","volume":"17","author":"Coester","year":"2000","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejps.2019.03.016_bb0060","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejpb.2005.09.009","article-title":"In vitro uptake of gelatin nanoparticles by murine dendritic cells and their intracellular localisation","volume":"62","author":"Coester","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2019.03.016_bb0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.03.016_bb0070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1081\/PDT-200031437","article-title":"Effect of process variables on particle size of gelatin microspheres containing lactic acid","volume":"9","author":"Dinarvand","year":"2004","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2019.03.016_bb0075","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jconrel.2013.09.019","article-title":"Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research","volume":"172","author":"Elzoghby","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2019.03.016_bb0080","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2012.04.036","article-title":"Protein-based nanocarriers as promising drug and gene delivery systems","volume":"161","author":"Elzoghby","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2019.03.016_bb0085","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijpharm.2011.02.049","article-title":"Mechanistic models facilitate efficient development of leucine containing microparticles for pulmonary drug delivery","volume":"409","author":"Feng","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.03.016_bb0090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.actbio.2017.06.012","article-title":"Improvement of endothelial progenitor outgrowth cell (EPOC)-mediated vascularization in gelatin-based hydrogels through pore size manipulation","volume":"58","author":"Fu","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejps.2019.03.016_bb0095","doi-asserted-by":"crossref","first-page":"136590","DOI":"10.1155\/2013\/136590","article-title":"In vitro release kinetics of antituberculosis drugs from nanoparticles assessed using a modified dissolution apparatus","volume":"2013","author":"Gao","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ejps.2019.03.016_bb0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0162-3109(00)00189-2","article-title":"Mechanisms of action of methotrexate","volume":"47","author":"Genestier","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.ejps.2019.03.016_bb0105","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ejpb.2011.04.017","article-title":"Paclitaxel loaded PEG(5000)-DSPE micelles as pulmonary delivery platform: formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation","volume":"79","author":"Gill","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2019.03.016_bb0110","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/10837450.2014.999786","article-title":"Gelatin-based particulate systems in ocular drug delivery","volume":"21","author":"Hathout","year":"2016","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2019.03.016_bb0115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2133\/dmpk.DMPK-13-RV-119","article-title":"Molecular basis for pharmacokinetics and pharmacodynamics of methotrexate in rheumatoid arthritis therapy","volume":"29","author":"Inoue","year":"2014","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2019.03.016_bb0120","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1080\/02664760802382426","article-title":"Optimization of parameters for the fabrication of gelatin nanoparticles by the Taguchi robust design method","volume":"35","author":"Jahanshahi","year":"2008","journal-title":"J. Appl. Stat."},{"key":"10.1016\/j.ejps.2019.03.016_bb0125","first-page":"695","article-title":"Determination of methotrexate in biological fluids and a parenteral injection using terbium-sensitized method","volume":"10","author":"Jouyban","year":"2011","journal-title":"Iran J. Pharm. Res."},{"key":"10.1016\/j.ejps.2019.03.016_bb0130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jcis.2014.12.092","article-title":"Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: in vitro and in vivo studies","volume":"445","author":"Jyoti","year":"2015","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2019.03.016_bb0135","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1007\/s11095-012-0958-3","article-title":"Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery","volume":"30","author":"Kulkarni","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2019.03.016_bb0140","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s11095-014-1538-5","article-title":"Bovine serum albumin adsorbed PGA-co-PDL nanocarriers for vaccine delivery via dry powder inhalation","volume":"32","author":"Kunda","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2019.03.016_bb0145","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ijpharm.2015.09.034","article-title":"Pulmonary dry powder vaccine of pneumococcal antigen loaded nanoparticles","volume":"495","author":"Kunda","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.03.016_bb0150","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2015.07.015","article-title":"Dry powder pulmonary delivery of cationic PGA-co-PDL nanoparticles with surface adsorbed model protein","volume":"492","author":"Kunda","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.03.016_bb0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0378-5173(98)00401-3","article-title":"Dynamic dialysis for the drug release evaluation from doxorubicin-gelatin nanoparticle conjugates","volume":"180","author":"Leo","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.03.016_bb0160","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/1556-276X-9-363","article-title":"Validation of a Janus role of methotrexate-based PEGylated chitosan nanoparticles in vitro","volume":"9","author":"Luo","year":"2014","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.ejps.2019.03.016_bb0165","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/aps.2017.34","article-title":"Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities","volume":"38","author":"Mangal","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejps.2019.03.016_bb0170","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1248\/cpb.c12-00823","article-title":"Statistical modeling, optimization and characterization of spray-dried solid self-microemulsifying drug delivery system using design of experiments","volume":"61","author":"Marasini","year":"2013","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejps.2019.03.016_bb0175","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.phymed.2016.10.020","article-title":"Selecting optimum protein nano-carriers for natural polyphenols using chemoinformatics tools","volume":"23","author":"Metwally","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejps.2019.03.016_bb0180","first-page":"149","article-title":"Synthesis of gelatin nanoparticles via simple coacervation","volume":"21","author":"Mohanty","year":"2005","journal-title":"J. Surface Sci.Technol."},{"key":"10.1016\/j.ejps.2019.03.016_bb0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0169-409X(99)00041-1","article-title":"The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs","volume":"40","author":"Nagayasu","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2019.03.016_bb0190","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/10717544.2016.1233588","article-title":"Optimizing novel penetration enhancing hybridized vesicles for augmenting the in-vivo effect of an anti-glaucoma drug","volume":"24","author":"Naguib","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1016\/j.ejps.2019.03.016_bb0195","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijpharm.2004.07.027","article-title":"The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine","volume":"285","author":"Najafabadi","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.03.016_bb0200","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/annonc\/mdw326","article-title":"Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Novello","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejps.2019.03.016_bb0205","first-page":"649","article-title":"HPLC-DAD and UV\u2013vis spectrophotometric methods for methotrexate assay in different biodegradable microparticles","volume":"26","author":"Oliveira","year":"2015","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.ejps.2019.03.016_bb0210","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijpharm.2013.04.009","article-title":"Spray dried inhalable ciprofloxacin powder with improved aerosolisation and antimicrobial activity","volume":"449","author":"Osman","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.03.016_bb0215","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mrgentox.2008.11.011","article-title":"Methotrexate-induced cytotoxicity and genotoxicity in germ cells of mice: intervention of folic and folinic acid","volume":"673","author":"Padmanabhan","year":"2009","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ejps.2019.03.016_bb0220","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00011-007-6115-5","article-title":"Optimized THP-1 differentiation is required for the detection of responses to weak stimuli","volume":"56","author":"Park","year":"2007","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejps.2019.03.016_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08982104.2015.1137313","article-title":"Augmented simvastatin cytotoxicity using optimized lipid nanocapsules: a potential for breast cancer treatment","volume":"27","author":"Safwat","year":"2017","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejps.2019.03.016_bb0230","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.colsurfb.2008.10.020","article-title":"Methotrexate-incorporated polymeric nanoparticles of methoxy poly(ethylene glycol)-grafted chitosan","volume":"69","author":"Seo","year":"2009","journal-title":"Colloids Surf. B Biointerfaces."},{"key":"10.1016\/j.ejps.2019.03.016_bb0235","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijpharm.2003.09.041","article-title":"Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung","volume":"269","author":"Sham","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.03.016_bb0240","doi-asserted-by":"crossref","first-page":"7632","DOI":"10.1039\/c4cc02595d","article-title":"A hyaluronic acid-methotrexate conjugate for targeted therapy of rheumatoid arthritis","volume":"50","author":"Shin","year":"2014","journal-title":"Chem. Commun. (Camb.)."},{"key":"10.1016\/j.ejps.2019.03.016_bb0245","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1021\/nn900451a","article-title":"Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols","volume":"3","author":"Shutava","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejps.2019.03.016_bb0250","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejpb.2012.10.015","article-title":"The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules","volume":"83","author":"Sou","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2019.03.016_bb0255","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1128\/IAI.67.11.5573-5578.1999","article-title":"Differentiation of monocytes to macrophages primes cells for lipopolysaccharide stimulation via accumulation of cytoplasmic nuclear factor kappaB","volume":"67","author":"Takashiba","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejps.2019.03.016_bb0260","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3109\/1061186X.2011.622404","article-title":"Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA","volume":"19","author":"Taratula","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejps.2019.03.016_bb0265","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1007\/s11095-011-0433-6","article-title":"Poly(glycerol adipate-co-omega-pentadecalactone) spray-dried microparticles as sustained release carriers for pulmonary delivery","volume":"28","author":"Tawfeek","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2019.03.016_bb0270","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijpharm.2012.10.036","article-title":"Dry powder inhalation of macromolecules using novel PEG-co-polyester microparticle carriers","volume":"441","author":"Tawfeek","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.03.016_bb0275","first-page":"865","article-title":"Conjugation of fluorescein isothiocyanate to antibodies: I. Experiments on the conditions of conjugation","volume":"18","author":"The","year":"1970","journal-title":"Immunology"},{"key":"10.1016\/j.ejps.2019.03.016_bb0280","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1073\/pnas.1018382108","article-title":"Multistage nanoparticle delivery system for deep penetration into tumor tissue","volume":"108","author":"Wong","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2019.03.016_bb0285","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijpharm.2008.02.011","article-title":"Inhaled nanoparticles\u2014a current review","volume":"356","author":"Yang","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.03.016_bb0290","first-page":"513","article-title":"The effects of surface morphology on the aerosol performance of spray-dried particles within HFA 134a based metered dose formulations","volume":"10","author":"Yang","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.03.016_bb0295","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1208\/s12249-010-9516-7","article-title":"Analysis of process parameters affecting spray-dried oily core nanocapsules using factorial design","volume":"11","author":"Zhang","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2019.03.016_bb0300","first-page":"22","article-title":"Gelatin nanoparticles as a new and simple gene delivery system","volume":"7","author":"Zwiorek","year":"2005","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.03.016_bb0305","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11095-007-9410-5","article-title":"Delivery by cationic gelatin nanoparticles strongly increases the immunostimulatory effects of CpG oligonucleotides","volume":"25","author":"Zwiorek","year":"2008","journal-title":"Pharm. Res."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098719301198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098719301198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:47:45Z","timestamp":1760528865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098719301198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":61,"alternative-id":["S0928098719301198"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2019.03.016","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploiting gelatin nanocarriers in the pulmonary delivery of methotrexate for lung cancer therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2019.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}